← Back to Skylight Health Group Stock
Skylight Health Group (SLHPF) News
TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ: SLHG , TSXV: SLHG ) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, is pleased to announce that it has closed the non-brokered private placement announced on August 8, 2022 (the "Offering"), issuing 2,355 units of unsecured convertible debentures ("Debentures"). The principal sum of Debentures issued totals C$2,355,000. Prad Sekar, CEO & Co-Founder of Skylight Health said, "We have a strong history of being diligent in our capital raising to ensure minimal dilution, and this cash injection gives us a buffer to get us comfortably to cash flow positivity." The Debentures will have a maturity date of thirty (30) months from the date of issuance and shall bear interest at the rate of 8% per annum, paid quarterly in shares. Each Debenture shall be convertible into 1,111 common shares of the Company at C$0.90 (" Common Shares "). Upon issuance of the Debenture a holder shall also receive 1,111 share purchase warrants (the " Warrants ") of the Company.
Skylight Health Group, Inc. (NASDAQ:SLHG ) Q2 2022 Earnings Conference Call August 16, 2022 8:00 AM ET Company Participants Pradyum Sekar - CEO Farooq Akhter - Interim CFO Conference Call Participants Rob Goff - Echelon Mike Freeman - Raymond James Operator Thank you, everyone, for standing by. This is the conference operator.
Skylight Health Group press release (SLHG): Q2 net loss from continuing operations during the three months ended June 30, 2022 was $5.2M.Revenue of $16.1M (+133.3% Y/Y) beats…
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that its financial results for the second quarter of 2022 will be released after the close of market on August 15th, 2022. The Company will host a conference call at 8:00am EDT on the morning of August 16, 2022 to discuss the financial results and outlook for the Company.
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that its financial results for the second quarter of 2022 will be released after the close of market on August 15th, 2022. The Company will host a conference call at 8:00am EDT on the morning of August 16, 2022 to discuss the financial results and outlook for the Company.
Skylight Health Group (SLHG) commences a non-brokered private placement offering of convertible debenture units at C$1,000 per debenture unit for total gross proceeds of up to…
Skylight Health Group (SLHG) has announced the re-appointment of Co-Founder and current Director and Chief Corporate Officer Kash Qureshi as President.Kash Qureshi, Co-Founder of…
Skylight Health Group (SLHG) said on Thursday it received a notification from the Nasdaq that the company was not in compliance with the minimum bid price. Nasdaq Listing Rule…
Farooq Akhter has been named interim CFO at Skylight Health Group (SLHG), effective June 15, 2022.Akhter joined Skylight in 2019 and has played a significant role as VP, Finance…
Skylight Health Group Inc. (NASDAQ:NASDAQ:SLHG) Q1 2022 Earnings Conference Call May 17, 2022 08:00 AM ET Company Participants Pradyum Sekar - CEO Andrew Elinesky - CFO Conference Call…